Harry E. Carmitchel
2009
In 2009, Harry E. Carmitchel earned a total compensation of $89.2K as Former Chief Operating Officer at Osiris Therapeutics, a 73% decrease compared to previous year.
Compensation breakdown
| Salary | $89,214 |
|---|---|
| Total | $89,214 |
Carmitchel received $89.2K in salary, accounting for 100% of the total pay in 2009.
Rankings
In 2009, Harry E. Carmitchel's compensation ranked 9,754th out of 9,885 executives tracked by ExecPay. In other words, Carmitchel earned more than 1.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,754 out of 9,885 | 1st |
Division Manufacturing | 3,641 out of 3,690 | 1st |
Major group Chemicals And Allied Products | 854 out of 871 | 2nd |
Industry group Drugs | 631 out of 643 | 2nd |
Industry Biological Products, Except Diagnostic Substances | 136 out of 138 | 1st |
Source: SEC filing on April 16, 2010.
Carmitchel's colleagues
We found five more compensation records of executives who worked with Harry E. Carmitchel at Osiris Therapeutics in 2009.
2009
C Mills
Osiris Therapeutics
Chief Executive Officer
2009
Lode Debrabandere
Osiris Therapeutics
Senior Vice President,
2009
Therapeutics Williams
Osiris Therapeutics
Chief Scientific Officer
2009
Richard Hunt
Osiris Therapeutics
Chief Financial Officer
2009
Philip Jacoby
Osiris Therapeutics